PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,323 | -58.6% | 695 | -50.0% | 0.00% | 0.0% |
| Q2 2023 | $51,479 | +117.9% | 1,390 | +100.0% | 0.00% | 0.0% |
| Q1 2023 | $23,630 | +90784.6% | 695 | -5.6% | 0.00% | 0.0% |
| Q4 2022 | $26 | -99.9% | 736 | -20.7% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | 0.0% | 928 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $36,000 | -40.0% | 917 | -43.1% | 0.00% | 0.0% |
| Q1 2022 | $60,000 | +42.9% | 1,612 | +131.9% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | +7.7% | 695 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $39,000 | +1850.0% | 695 | +2680.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -77.8% | 25 | -83.4% | 0.00% | – |
| Q4 2020 | $9,000 | -88.9% | 151 | -88.9% | 0.00% | -100.0% |
| Q3 2020 | $81,000 | – | 1,358 | – | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | +200.0% | 200 | +100.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 100 | -9.9% | 0.00% | – |
| Q2 2016 | $4,000 | -50.0% | 111 | +11.0% | 0.00% | -100.0% |
| Q4 2015 | $8,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |